vita coco co. - COCO
COCO
Close Chg Chg %
36.63 -0.51 -1.39%
Closed Market
36.12
-0.51 (1.39%)
Volume: 344.26K
Last Updated:
Nov 22, 2024, 4:00 PM EDT
Company Overview: vita coco co. - COCO
COCO Key Data
| Open $36.60 | Day Range 36.01 - 36.97 |
| 52 Week Range 19.41 - 37.04 | Market Cap $2.08B |
| Shares Outstanding 56.73M | Public Float 38.45M |
| Beta 0.22 | Rev. Per Employee N/A |
| P/E Ratio 36.52 | EPS $1.05 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 638.17K |
COCO Performance
| 1 Week | 6.17% | ||
| 1 Month | 22.73% | ||
| 3 Months | 45.12% | ||
| 1 Year | 23.15% | ||
| 5 Years | N/A |
COCO Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
10
Full Ratings ➔
About vita coco co. - COCO
The Vita Coco Co., Inc. produces, supplies and distributes coconut water. The firm offers coconut water, sparkling water, coconut milk, and oil products. It carries out its operations through its Americas and International segments. The Americas segment consists of the marketing and distribution of coconut and non-coconut water products in the US and Canada. The International segment includes the company's procurement arm and derives its revenues from the marketing and distribution of coconut water and non-coconut water products in Europe, the Middle East, and Asia Pacific. Its brands include Vita Coco, Runa, and Ever & Ever. The company was founded by Michael Kirban and Ira Liran in 2004 and is headquartered in New York, NY.
COCO At a Glance
The Vita Coco Co., Inc.
250 Park Avenue South
New York, New York 10003
| Phone | 1-212-206-0763 | Revenue | 493.61M | |
| Industry | Food: Major Diversified | Net Income | 46.63M | |
| Sector | Consumer Non-Durables | 2023 Sales Growth | 15.387% | |
| Fiscal Year-end | 12 / 2024 | Employees | 294 | |
| View SEC Filings |
COCO Valuation
| P/E Current | 36.517 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 32.317 |
| Price to Sales Ratio | 3.053 |
| Price to Book Ratio | 7.209 |
| Price to Cash Flow Ratio | 14.063 |
| Enterprise Value to EBITDA | 24.07 |
| Enterprise Value to Sales | 2.787 |
| Total Debt to Enterprise Value | 0.001 |
COCO Efficiency
| Revenue/Employee | 1,678,952.381 |
| Income Per Employee | 158,602.041 |
| Receivables Turnover | 7.439 |
| Total Asset Turnover | 2.022 |
COCO Liquidity
| Current Ratio | 3.184 |
| Quick Ratio | 2.551 |
| Cash Ratio | 1.609 |
COCO Profitability
| Gross Margin | 36.48 |
| Operating Margin | 11.445 |
| Pretax Margin | 11.734 |
| Net Margin | 9.446 |
| Return on Assets | 19.10 |
| Return on Equity | 27.147 |
| Return on Total Capital | 22.847 |
| Return on Invested Capital | 26.949 |
COCO Capital Structure
| Total Debt to Total Equity | 0.817 |
| Total Debt to Total Capital | 0.81 |
| Total Debt to Total Assets | 0.574 |
| Long-Term Debt to Equity | 0.223 |
| Long-Term Debt to Total Capital | 0.221 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Vita Coco Co. - COCO
Collapse All in section
| All values USD millions. | 2020 | 2021 | 2022 | 2023 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 310.64M | 379.51M | 427.79M | 493.61M | |
Sales Growth
| +9.40% | +22.17% | +12.72% | +15.39% | |
Cost of Goods Sold (COGS) incl D&A
| 207.01M | 268.43M | 326.33M | 313.54M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 2.13M | 2.07M | 2.96M | 660.00K | |
Depreciation
| 905.00K | 849.00K | 1.74M | 660.00K | |
Amortization of Intangibles
| - | 1.22M | 1.22M | 1.22M | |
COGS Growth
| +7.71% | +29.67% | +21.57% | -3.92% | |
Gross Income
| 103.64M | 111.08M | 101.46M | 180.07M | |
Gross Income Growth
| +12.95% | +7.18% | -8.66% | +77.48% | |
Gross Profit Margin
| +33.36% | +29.27% | +23.72% | +36.48% |
| 2020 | 2021 | 2022 | 2023 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 73.18M | 86.49M | 91.69M | 123.58M | |
Research & Development
| - | 477.00K | 541.00K | 418.00K | |
Other SG&A
| 73.18M | 86.01M | 91.15M | 123.16M | |
SGA Growth
| -5.79% | +18.19% | +6.01% | +34.77% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| (11.68M) | (1.96M) | 108.00K | 872.00K | |
EBIT after Unusual Expense
| 42.14M | 26.55M | 9.66M | 55.62M | |
Non Operating Income/Expense
| 2.25M | (1.96M) | 1.44M | 2.33M | |
Non-Operating Interest Income
| 404.00K | 127.00K | 51.00K | 2.58M | |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 791.00K | 360.00K | 258.00K | 31.00K | |
Interest Expense Growth
| -31.99% | -54.49% | -28.33% | -87.98% | |
Gross Interest Expense
| 791.00K | 360.00K | 258.00K | 31.00K | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 43.60M | 24.23M | 10.84M | 57.92M | |
Pretax Income Growth
| +282.42% | -44.43% | -55.26% | +434.27% | |
Pretax Margin
| +14.04% | +6.38% | +2.53% | +11.73% | |
Income Tax
| 10.91M | 5.24M | 3.03M | 11.29M | |
Income Tax - Current - Domestic
| 2.76M | 4.42M | 5.13M | 8.84M | |
Income Tax - Current - Foreign
| 1.88M | 2.44M | 965.00K | 4.94M | |
Income Tax - Deferred - Domestic
| 6.29M | (333.00K) | (3.78M) | (2.67M) | |
Income Tax - Deferred - Foreign
| (5.00K) | (1.28M) | 710.00K | 187.00K | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 32.69M | 18.99M | 7.81M | 46.63M | |
Minority Interest Expense
| - | - | 27.00K | (23.00K) | - |
Net Income
| 32.66M | 19.02M | 7.81M | 46.63M | |
Net Income Growth
| +246.82% | -41.78% | -58.91% | +496.74% | |
Net Margin Growth
| +10.51% | +5.01% | +1.83% | +9.45% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 32.66M | 19.02M | 7.81M | 46.63M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 32.66M | 19.02M | 7.81M | 46.63M | |
EPS (Basic)
| 0.5885 | 0.3422 | 0.1402 | 0.8264 | |
EPS (Basic) Growth
| +246.79% | -41.85% | -59.03% | +489.44% | |
Basic Shares Outstanding
| 55.50M | 55.56M | 55.73M | 56.43M | |
EPS (Diluted)
| 0.5885 | 0.3422 | 0.1392 | 0.7937 | |
EPS (Diluted) Growth
| +246.79% | -41.85% | -59.32% | +470.19% | |
Diluted Shares Outstanding
| 55.50M | 55.56M | 56.12M | 58.75M | |
EBITDA
| 32.58M | 26.66M | 12.73M | 57.15M | |
EBITDA Growth
| +101.71% | -18.18% | -52.25% | +349.03% | |
EBITDA Margin
| +10.49% | +7.02% | +2.98% | +11.58% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 31.00 | |
| Number of Ratings | 10 | Current Quarters Estimate | 0.066 | |
| FY Report Date | 12 / 2024 | Current Year's Estimate | 0.984 | |
| Last Quarter’s Earnings | 0.32 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 0.79 | Next Fiscal Year Estimate | 1.126 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 10 | 8 | 10 | 10 |
| Mean Estimate | 0.07 | 0.22 | 0.98 | 1.13 |
| High Estimates | 0.11 | 0.28 | 1.11 | 1.27 |
| Low Estimate | 0.04 | 0.12 | 0.92 | 1.01 |
| Coefficient of Variance | 37.93 | 23.05 | 6.76 | 7.03 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 6 | 6 | 6 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 4 | 4 | 4 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Vita Coco Co. - COCO
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Vita Coco Co. - COCO
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Jun 21, 2024 | Ira Liran Director | 943,729 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $29.53 per share | 27,868,317.37 |
| Jun 21, 2024 | Ira Liran Director | 634,426 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $29.54 per share | 18,740,944.04 |
| Jun 19, 2024 | Charles van Es Chief Sales Officer | 97,668 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $30.06 per share | 2,935,900.08 |
| Jun 19, 2024 | Jonathan Burth Chief Operating Officer | 134,004 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $30.07 per share | 4,029,500.28 |
| Jun 19, 2024 | Charles van Es Chief Sales Officer | 100,473 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $10.18 per share | 1,022,815.14 |
| Jun 19, 2024 | Jane Prior Chief Marketing Officer | 132,198 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $10.18 per share | 1,345,775.64 |
| Jun 19, 2024 | Jane Prior Chief Marketing Officer | 110,815 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Jun 19, 2024 | Jonathan Burth Chief Operating Officer | 127,168 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $30.04 per share | 3,820,126.72 |
| Jun 19, 2024 | Jane Prior Chief Marketing Officer | 138,535 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $10.18 per share | 1,410,286.30 |
| Jun 19, 2024 | Jane Prior Chief Marketing Officer | 131,834 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $30.06 per share | 3,962,930.04 |
| Jun 19, 2024 | Jane Prior Chief Marketing Officer | 131,834 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $30 per share | 3,955,020.00 |
| Jun 19, 2024 | Charles van Es Chief Sales Officer | 97,668 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $30.04 per share | 2,933,946.72 |
| Jun 19, 2024 | Jane Prior Chief Marketing Officer | 103,750 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Jun 19, 2024 | Jane Prior Chief Marketing Officer | 104,114 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Jun 19, 2024 | Jane Prior Chief Marketing Officer | 131,834 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $30.04 per share | 3,960,293.36 |
| Jun 19, 2024 | Charles van Es Chief Sales Officer | 97,668 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $30.01 per share | 2,931,016.68 |
| Jun 19, 2024 | Jane Prior Chief Marketing Officer | 134,769 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $10.18 per share | 1,371,948.42 |
| Jun 19, 2024 | Jonathan Burth Chief Operating Officer | 126,849 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $30 per share | 3,805,470.00 |
| Jun 19, 2024 | Charles van Es Chief Sales Officer | 104,368 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $10.18 per share | 1,062,466.24 |
| Jun 19, 2024 | Charles van Es Chief Sales Officer | 103,791 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $10.18 per share | 1,056,592.38 |